Abstract
Synthesis of a novel series of DPPIV inhibitors with 1,2,4- and 1,3,4-oxadiazolyl ketone derivatives and its structure-activity relationships are discussed. Compound 18h showed good inhibitory activity against DPPIV and favorable pharmacokinetic properties. In vivo pharmacodynamic efficacy and co-crystal structure of compound 18h with DPPIV is also described.
MeSH terms
-
Animals
-
Crystallography, X-Ray
-
Dipeptidyl Peptidase 4 / metabolism
-
Dipeptidyl-Peptidase IV Inhibitors*
-
Dogs
-
Haplorhini
-
Ketones / chemical synthesis*
-
Ketones / chemistry*
-
Ketones / pharmacology
-
Kinetics
-
Models, Molecular
-
Molecular Structure
-
Protease Inhibitors / chemical synthesis*
-
Protease Inhibitors / chemistry*
-
Protease Inhibitors / pharmacology
-
Rats
-
Structure-Activity Relationship
Substances
-
Dipeptidyl-Peptidase IV Inhibitors
-
Ketones
-
Protease Inhibitors
-
Dipeptidyl Peptidase 4